In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels.

Volume: 39, Issue: 8, Pages: 949 - 957
Published: May 19, 2021
Abstract
Most known pathogenic point mutations in humans are C•G to T•A substitutions, which can be directly repaired by adenine base editors (ABEs). In this study, we investigated the efficacy and safety of ABEs in the livers of mice and cynomolgus macaques for the reduction of blood low-density lipoprotein (LDL) levels. Lipid nanoparticle-based delivery of mRNA encoding an ABE and a single-guide RNA targeting PCSK9, a negative regulator of LDL, induced...
Paper Details
Title
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels.
DOI
Published Date
May 19, 2021
Journal
Volume
39
Issue
8
Pages
949 - 957
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.